| Code | 7434D | ||||||||||
| MA number | 21/0121/21-S | ||||||||||
| Product Form: | tbl 30x800 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.06.2021 |
| Validity: | 16.06.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Arupsan 800 mg tablety_03.2023.pdf
|
| SPC: |
SPC_Arupsan 800 mg tablety_03.2023.pdf
|
| Safety feature | Yes |
| Data update: | 30.03.2023 |
